Apremilast for the Treatment of Palmoplantar Pustulosis Apremilast for the Treatment of Palmoplantar Pustulosis

This study assessed the efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, for the treatment of Japanese patients with palmoplantar pustulosis refractory to topical therapy.American Journal of Clinical Dermatology

Source: Medscape Today Headlines - September 19, 2023 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news